Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease
Top Cited Papers
- 7 June 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 111 (22) , 2906-2912
- https://doi.org/10.1161/circulationaha.104.521864
Abstract
Background— Percutaneous coronary intervention (PCI) has been shown to improve symptoms compared with conservative medical treatment in patients with stable coronary artery disease (CAD); however, there is limited evidence on the effect of PCI on the risk of death, myocardial infarction, and subsequent revascularization. Therefore, we performed a meta-analysis of 11 randomized trials comparing PCI to conservative treatment in patients with stable CAD.Keywords
This publication has 30 references indexed in Scilit:
- Meta-analysis comparing drug-eluting stents with bare metal stentsThe American Journal of Cardiology, 2005
- Indications for Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention in Chronic Stable AnginaCirculation, 2003
- Randomized Comparison of Percutaneous Transluminal Coronary Angioplasty and Medical Therapy in Stable Survivors of Acute Myocardial Infarction With Single Vessel DiseaseCirculation, 2003
- Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisBMJ, 2003
- Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular DiseaseCirculation, 2003
- Bayesian random effects meta‐analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scalesStatistics in Medicine, 2002
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Two- to three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy (results of a VA cooperative study)The American Journal of Cardiology, 1998
- Rationale, Design, and Baseline Characteristics of a Trial Comparing Aggressive Lipid Lowering With Atorvastatin Versus Revascularization Treatments (AVERT) fn1fn1This work is supported by a grant from Parke-Davis Pharmaceutical Research, a Division of Warner-Lambert Company, Ann Arbor, Michigan.The American Journal of Cardiology, 1997
- The Medicine, Angioplasty or Surgery Study (MASS): A prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenosesJournal of the American College of Cardiology, 1995